Systemically administered collagen-targeted gold nanoparticles bind to arterial injury following vascular interventions. - Wikidata - wikimedia - TriplyDB

Systemically administered collagen-targeted gold nanoparticles bind to arterial injury following vascular interventions.

Systemically administered collagen-targeted gold nanoparticles bind to arterial injury following vascular interventions.

http://www.wikidata.org/entity/Q37670254

about

Recent Advances in Managing Atherosclerosis via Nanomedicine.

P2860

Q47251361-0E535D19-D8A4-4DFE-95EC-3C5FF43BAB65

P2860

Systemically administered collagen-targeted gold nanoparticles bind to arterial injury following vascular interventions.

http://www.wikidata.org/entity/Q37670254

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Systemically administered coll ...... lowing vascular interventions.

@en

Systemically administered coll ...... lowing vascular interventions.

@nl

type

label

Systemically administered coll ...... lowing vascular interventions.

@en

Systemically administered coll ...... lowing vascular interventions.

@nl

prefLabel

Systemically administered coll ...... lowing vascular interventions.

@en

Systemically administered coll ...... lowing vascular interventions.

@nl

P1433

Q37670254-A838320A-28D7-4F12-8FED-11B866698984

P1476

Q37670254-3B5282A6-FFE2-47FA-A5FE-DE858F723EF2

P2093

Q37670254-235B5C20-96E3-43ED-8106-1F6205864908

Q37670254-2D1722CA-A6C6-4F54-BB36-BBD35B3BAF39

Q37670254-5E92981D-DF05-4195-ABB7-E194983E27FD

Q37670254-6C70D200-DCFC-4BD2-BA24-C7738573C7D7

Q37670254-AAC8FDD5-E857-4C87-AAAF-6AFD3E59417E

Q37670254-D5EF0DA1-47E0-43A7-B771-0425E034DB5C

Q37670254-D9E05388-1CEB-4E9D-9064-DCBFE8F63A33

P2860

Q37670254-033AD42B-65CA-4934-93AC-7B26BDD927F5

Q37670254-056BED63-56FB-414A-A1AB-8DA0B0777006

Q37670254-09B0A8B0-9A57-4923-936B-98AB4BA4F7AB

Q37670254-0B4EECB8-7030-48ED-9C1A-FD4EFA5CD5B0

Q37670254-0CBE79F0-A466-4F0C-9855-6D1807CE0766

Q37670254-0ED15450-9FD1-4AFD-9011-48B03BEC9F87

Q37670254-1156DF18-D2C9-44B2-9739-FD28B13A18E4

Q37670254-16AD9607-6CE9-48D5-8008-2057A8D479A2

Q37670254-1773E043-744C-47DF-A0EE-51D35DCF416A

Q37670254-1B8FCDEB-D4B6-4251-B14A-5AC21941ED7C

P31

Q37670254-F2D2FB35-576B-4C2E-953A-60EADAB030B8

P356

Q37670254-230B5990-86E7-4182-A0E2-85030A8152DD

P433

Q37670254-A36DC107-0815-4C9C-A8F5-7E11436530F8

P478

Q37670254-C0372E20-D6CF-47A2-8F86-25BE19AD749E

P577

Q37670254-50320435-325F-415E-AF21-5543FD5B51AD

P698

Q37670254-AE297C06-D9C2-4695-B4DF-404BE7C90C8A

P932

Q37670254-0E469C96-CD6A-4EAA-BA9C-CD61257A9B4A

P356

P1433

Physiological Reports

P1476

Systemically administered coll ...... lowing vascular interventions.

@en

P2093

Colby S Thaxton

http://www.w3.org/2001/XMLSchema#string

Janet M Vercammen

http://www.w3.org/2001/XMLSchema#string

Jonathan S Rink

http://www.w3.org/2001/XMLSchema#string

Megan E Kelly

http://www.w3.org/2001/XMLSchema#string

Melina R Kibbe

http://www.w3.org/2001/XMLSchema#string

Molly Wasserman Meyers

http://www.w3.org/2001/XMLSchema#string

Qun Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology

Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview.

Spatiotemporal controlled delivery of nanoparticles to injured vasculature

Update on current and potential nanoparticle cancer therapies

Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.

First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement.

P31

scholarly article

P356

10.14814/PHY2.13128

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28242820

http://www.w3.org/2001/XMLSchema#string

P932

5328771

http://www.w3.org/2001/XMLSchema#string